Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wichard

Showing results (191-200 of 218) with videos related to

Pageof 22
Sort By:
Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7Chris Barber, Alexander Amberg, Laura Custer, et al.
Regulatory Toxicology and Pharmacology : RTP|January 20, 2016
It's difficult, but important, to make negative predictionsRichard V Williams, Alexander Amberg, Alessandro Brigo, et al.
Plos One|October 7, 2016
Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune CellsRené H M Raeven, Jolanda Brummelman, Larissa van der Maas, et al.
Regulatory Toxicology and Pharmacology : RTP|December 29, 2015
Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtainedChris Barber, Alex Cayley, Thierry Hanser, et al.
Blood|June 10, 2010
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyWolfgang A Bethge, Thoralf Lange, Christoph Meisner, et al.
Journal of Proteome Research|May 20, 2015
Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral ImmunogenicityRené H M Raeven, Larissa van der Maas, Wichard Tilstra, et al.
Scientific Reports|December 2, 2016
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccineRené H M Raeven, Jolanda Brummelman, Jeroen L A Pennings, et al.
Journal of Dairy Science|May 24, 2021
Aspects of transition cow metabolomics-Part I: Effects of a metaphylactic butaphosphan and cyanocobalamin treatment on the metabolome in liver, blood, and urine in cows with different liver metabotypesM Schären, T Snedec, B Riefke, et al.
Journal of Hematology & Oncology|August 16, 2023
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual diseaseJonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.
Pageof 22

Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7Chris Barber, Alexander Amberg, Laura Custer, et al.
Regulatory Toxicology and Pharmacology : RTP|January 20, 2016
It's difficult, but important, to make negative predictionsRichard V Williams, Alexander Amberg, Alessandro Brigo, et al.
Plos One|October 7, 2016
Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune CellsRené H M Raeven, Jolanda Brummelman, Larissa van der Maas, et al.
Regulatory Toxicology and Pharmacology : RTP|December 29, 2015
Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtainedChris Barber, Alex Cayley, Thierry Hanser, et al.
Blood|June 10, 2010
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyWolfgang A Bethge, Thoralf Lange, Christoph Meisner, et al.
Journal of Proteome Research|May 20, 2015
Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral ImmunogenicityRené H M Raeven, Larissa van der Maas, Wichard Tilstra, et al.
Scientific Reports|December 2, 2016
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccineRené H M Raeven, Jolanda Brummelman, Jeroen L A Pennings, et al.
Journal of Dairy Science|May 24, 2021
Aspects of transition cow metabolomics-Part I: Effects of a metaphylactic butaphosphan and cyanocobalamin treatment on the metabolome in liver, blood, and urine in cows with different liver metabotypesM Schären, T Snedec, B Riefke, et al.
Journal of Hematology & Oncology|August 16, 2023
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual diseaseJonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.
Pageof 22